According to the results of a recent study, researchers have found a treatment that completely removed the rectal cancer in every patient that participated. Meaning that every single patient in the study is in remission—and with no chemotherapy, no radiation, and no surgery.
According to the results of a recent study, researchers have found a treatment that completely removed the rectal cancer in every patient that participated... www.theepochtimes.com |
Study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma.

No comments:
Post a Comment